Search research articles
Contact Us
Filters
Showing results (11-20 of 136) with videos related to
Page
of 14
Sort By:
Cancer Immunology, Immunotherapy : CII
|
September 3, 2021
MAIT cells numbers and frequencies in patients with acute myeloid leukemia at diagnosis: association with cytogenetic profile and gene mutations
Thibault Comont, Marie-Laure Nicolau-Travers, Sarah Bertoli, et al.
Leukemia Research
|
July 15, 2010
Overdose with 16,000 mg of imatinib mesylate
Emilie Dehours, Béatrice Riu, Baptiste Valle, et al.
Ejhaem
|
June 19, 2024
When acute promyelocytic leukaemia changes its face in the peripheral blood
Sophie Le Grand, Alban Canali, Sarah Bertoli, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
January 24, 2020
Cost-effectiveness of midostaurin in the treatment of newly diagnosed FLT3-mutated acute myeloid leukemia in France
Gabriel Tremblay, Clemence Cariou, Christian Recher, et al.
International Journal of Cancer
|
January 13, 2005
Single-cell analysis of loss of heterozygosity at the ATM gene locus in Hodgkin and Reed-Sternberg cells of Hodgkin's lymphoma: ATM loss of heterozygosity is a rare event
Virginie Lespinet, Fanny Terraz, Christian Recher, et al.
Annals of Hematology
|
April 27, 2016
Use of rifampin for treatment of disseminated tuberculosis in a patient with primary myelofibrosis on ruxolitinib
Benoit Branco, David Metsu, Marine Dutertre, et al.
Hematological Oncology
|
June 17, 2017
Bendamustine for relapsed blastic plasmacytoid dendritic cell leukaemia
Sarah Bétrian, Sarah Guenounou, Isabelle Luquet, et al.
Blood
|
August 17, 2006
Syk-dependent mTOR activation in follicular lymphoma cells
Ludivine Leseux, Safouane M Hamdi, Talal Al Saati, et al.
Oral Oncology
|
November 14, 2020
Oral acute graft versus host disease after donor lymphocyte infusions: Clinicopathological characterization in a monocenter cohort
Nuno Gomes, Anne Huynh, Cécile Borel, et al.
European Journal of Haematology
|
June 19, 2014
Clinical activity of a new regimen combining gemcitabine and alemtuzumab in high-risk relapsed/refractory chronic lymphocytic leukemia patients
Lucie Oberic, Willy Vaillant, Benjamin Hebraud, et al.
Page
of 14
Search research articles
Search
Showing results (11-20 of 136) with videos related to
Sort By:
Page
of 14
Cancer Immunology, Immunotherapy : CII
|
September 3, 2021
MAIT cells numbers and frequencies in patients with acute myeloid leukemia at diagnosis: association with cytogenetic profile and gene mutations
Thibault Comont, Marie-Laure Nicolau-Travers, Sarah Bertoli, et al.
Leukemia Research
|
July 15, 2010
Overdose with 16,000 mg of imatinib mesylate
Emilie Dehours, Béatrice Riu, Baptiste Valle, et al.
Ejhaem
|
June 19, 2024
When acute promyelocytic leukaemia changes its face in the peripheral blood
Sophie Le Grand, Alban Canali, Sarah Bertoli, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
January 24, 2020
Cost-effectiveness of midostaurin in the treatment of newly diagnosed FLT3-mutated acute myeloid leukemia in France
Gabriel Tremblay, Clemence Cariou, Christian Recher, et al.
International Journal of Cancer
|
January 13, 2005
Single-cell analysis of loss of heterozygosity at the ATM gene locus in Hodgkin and Reed-Sternberg cells of Hodgkin's lymphoma: ATM loss of heterozygosity is a rare event
Virginie Lespinet, Fanny Terraz, Christian Recher, et al.
Annals of Hematology
|
April 27, 2016
Use of rifampin for treatment of disseminated tuberculosis in a patient with primary myelofibrosis on ruxolitinib
Benoit Branco, David Metsu, Marine Dutertre, et al.
Hematological Oncology
|
June 17, 2017
Bendamustine for relapsed blastic plasmacytoid dendritic cell leukaemia
Sarah Bétrian, Sarah Guenounou, Isabelle Luquet, et al.
Blood
|
August 17, 2006
Syk-dependent mTOR activation in follicular lymphoma cells
Ludivine Leseux, Safouane M Hamdi, Talal Al Saati, et al.
Oral Oncology
|
November 14, 2020
Oral acute graft versus host disease after donor lymphocyte infusions: Clinicopathological characterization in a monocenter cohort
Nuno Gomes, Anne Huynh, Cécile Borel, et al.
European Journal of Haematology
|
June 19, 2014
Clinical activity of a new regimen combining gemcitabine and alemtuzumab in high-risk relapsed/refractory chronic lymphocytic leukemia patients
Lucie Oberic, Willy Vaillant, Benjamin Hebraud, et al.
Page
of 14